PreveCeutical Medical Inc (PRVCF)
OTHER OTC:PRVCF

PreveCeutical Medical (PRVCF) Stock Price & Analysis

37 Followers

PRVCF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.01 - $0.03
Previous Close$0.02
Volume308.15K
Average Volume (3M)49.00K
Market Cap
$7.87M
Enterprise Value$10.79M
Total Cash (Recent Filing)C$2.81K
Total Debt (Recent Filing)C$4.03M
Price to Earnings (P/E)
Beta0.14
Aug 22, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding535,303,359
10 Day Avg. Volume26,444
30 Day Avg. Volume49,003
Standard Deviation0.27
R-Squared0.01
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)-2.39
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-67.90
P/FCF Ratio105.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

21.02%0.00%0.00%78.98%
21.02% Insiders
0.00% Other Institutional Investors
78.98% Public Companies and
Individual Investors

PRVCF FAQ

What was PreveCeutical Medical Inc’s price range in the past 12 months?
PreveCeutical Medical Inc lowest stock price was $0.01 and its highest was $0.03 in the past 12 months.
    What is PreveCeutical Medical Inc’s market cap?
    Currently, no data Available
    When is PreveCeutical Medical Inc’s upcoming earnings report date?
    PreveCeutical Medical Inc’s upcoming earnings report date is Aug 22, 2024 which is in 28 days.
      How were PreveCeutical Medical Inc’s earnings last quarter?
      Currently, no data Available
      Is PreveCeutical Medical Inc overvalued?
      According to Wall Street analysts PreveCeutical Medical Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does PreveCeutical Medical Inc pay dividends?
        PreveCeutical Medical Inc does not currently pay dividends.
        What is PreveCeutical Medical Inc’s EPS estimate?
        PreveCeutical Medical Inc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does PreveCeutical Medical Inc have?
        PreveCeutical Medical Inc has 539,903,400 shares outstanding.
          What happened to PreveCeutical Medical Inc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of PreveCeutical Medical Inc?
          Currently, no hedge funds are holding shares in PRVCF
          ---

          PreveCeutical Medical Stock Smart Score

          10
          Unlock Smart Score
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Technicals

          SMA
          Negative
          20 days / 200 days
          Momentum
          20.00%
          12-Months-Change

          Fundamentals

          Return on Equity
          Trailing 12-Months
          Asset Growth
          11.67%
          Trailing 12-Months

          Company Description

          PreveCeutical Medical Inc

          PreveCeutical Medical, Inc. engages in licensing, branding and marketing of nutraceutical and wellness products. Its product include cellb9 immune system booster, which is an oral solution. PreveCeutical Medical was founded by Stephen Van Deventer, Kimberly Van Deventer, Greg Reid, Shabira Rajan, Mak Jawadekar, Harry Parekh, Nicole Goncalves-Krysinski, Lish Rebman and Sydney Cole on December 15, 2014 and is headquartered in Vancouver, Canada.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Applied DNA Sciences
          TherapeuticsMD
          Brainstorm Cell Therapeutics
          Ardelyx
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis